ArticleDiagnostics (Basel, Switzerland)2023
Mobile Cone-Beam CT-Assisted Bronchoscopy for Peripheral Lung Lesions.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Surgical Process Modeling of Workflow and Performance in Image-Guided Bronchoscopy.Annals of biomedical engineering · 2025Article
- Surgical Process Modeling of Workflow and Performance in Image-Guided Bronchoscopy.Annals of biomedical engineering · 2025Article
- Efficacy and safety of cone-beam computed tomography-guided bronchoscopy for peripheral pulmonary lesions: a systematic review and meta-analysis.Journal of thoracic disease · 2025Article
- Bedside to bench and back again-translational research in interventional pulmonology.Current opinion in pulmonary medicine · 2025Review
- Determinants of radiation exposure during mobile cone-beam CT-guided robotic-assisted bronchoscopy.Respirology (Carlton, Vic.) · 2024Article
- State of the art: peripheral diagnostic bronchoscopy.Journal of thoracic disease · 2024Review
- The Diagnostic Yield of Cone Beam CT Combined With Radial-Endobronchial Ultrasound for the Diagnosis of Peripheral Pulmonary Nodules: Systematic Review and Meta-Analysis.CHEST pulmonary · 2024Article
- Article
- New developments in the imaging of lung cancer.Breathe (Sheffield, England) · 2024Review
- Radiation Principles, Protection, and Reporting for Interventional Pulmonology: A World Association of Bronchology and Interventional Pulmonology White Paper.Respiration; international review of thoracic diseases · 2024Article
- Simplicity Is the Ultimate Sophistication: A Unified Definition of Diagnostic Yield Is Imperative for the Appropriate Diagnosis of Peripheral Lung Lesions.Annals of the American Thoracic Society · 2023Article
- Radiation dose of cone beam CT combined with shape sensing robotic assisted bronchoscopy for the evaluation of pulmonary lesions: an observational single center study.Journal of thoracic disease · 2023Article
- Digital Tomosynthesis: Review of Current Literature and Its Impact on Diagnostic Bronchoscopy.Diagnostics (Basel, Switzerland) · 2023Review
- SuccessfulCase reports in oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripheral bronchoscopy with the use of thin/ultrathin bronchoscopes and radial-probe endobronchial ultrasound (RP-EBUS) has been associated with a fair diagnostic yield. Mobile cone-beam CT (m-CBCT) could potentially improve the performance of these readily available technologies. We retrospectively reviewed the records of patients undergoing bronchoscopy for peripheral lung lesions with thin/ultrathin scope, RP-EBUS, and m-CBCT guidance. We studied the performance (diagnostic yield and sensitivity for malignancy) and safety (complications, radiation exposure) of this combined approach. A total of 51 patients were studied. The mean target size was 2.6 cm (SD, 1.3 cm) and the mean distance to the pleura was 1.5 cm (SD, 1.4 cm). The diagnostic yield was 78.4% (95 CI, 67.1-89.7%), and the sensitivity for malignancy was 77.4% (95 CI, 62.7-92.1%). The only complication was one pneumothorax. The median fluoroscopy time was 11.2 min (range, 2.9-42.1) and the median number of CT spins was 1 (range, 1-5). The mean Dose Area Product from the total exposure was 41.92 Gy·cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.